Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FP9AS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,731
Award facts
- Contract value 100% obligated
- $50,731.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,731.23 delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Dupixent 300 mg/2 mL pen injectors. This is a firm fixed-price, non-competitive delivery order with a completion date of January 30, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The IDC enables the company to supply a broad range of pharmaceuticals and medical commodities, including specialty medications, brand-name and generic drugs, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. Dupixent is a biologic immunosuppressant used to treat conditions such as atopic dermatitis, asthma, and eosinophilic disorders, reflecting the contract's focus on specialized therapeutic medications for military medical treatment facilities.
Quick answers
Who was awarded contract SPE2DR26FP9AS?
SPE2DR26FP9AS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FP9AS worth?
The government has obligated $50,731 on SPE2DR26FP9AS.
Is contract SPE2DR26FP9AS an order under another contract?
Yes. SPE2DR26FP9AS is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP9AS competed?
The extent of competition for SPE2DR26FP9AS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award